AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
David Scott Miller

David Scott Miller

University of Texas Southwestern - Dallas / United States
Medical and Health Sciences / Obstetrics and Gynecology
AD Scientific Index ID: 1679526
University of Texas Southwestern Medical Center
person_outline David Scott Miller's MOST POPULAR ARTICLES
1-) Lenvatinib plus pembrolizumab for advanced endometrial cancer New England Journal of Medicine 386 (5), 437-448, 2022
2-) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study Journal of Clinical Oncology 22 (15), 3113-3119, 2004
3-) Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study Journal of Clinical Oncology 23 (21), 4626-4633, 2005
4-) Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Journal of the National Comprehensive Cancer Network 19 (2), 191-226, 2021
5-) Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial The Lancet Oncology 20 (5), 636-648, 2019